Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT03994653Completed

Cancer Loyalty Card Study

Role: collaborator

NCT02563600Not ApplicableRecruiting

Effect of Brief-tele Support on Attendance at Physiotherapy Sessions

Role: collaborator

NCT02549157Recruiting

Treatments for Urogynaecological Problems and Patient Selfreports

Role: collaborator

NCT04590365Not ApplicableCompleted

Carrageenan Nasal Spray for COVID-19 Prophylaxis

Role: collaborator

NCT03266809Completed

CARdiac Function Evaluation in Breast Cancer Patients

Role: collaborator

NCT03325231Completed

Factors Influencing Patient Choice of Bladder Reconstruction Following Radical Cystectomy

Role: collaborator

NCT04663360Not ApplicableCompleted

Medication Monitoring for Older Adults in Primary Care

Role: collaborator

NCT03110471Completed

Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation

Role: collaborator

All 8 trials loaded